Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia - Scorecard - MDSpire

Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia

  • By

  • Xiandan Chen

  • Linlu Ying

  • Weixing Kong

  • Wangxiong Hu

  • Zhong Hu

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: Development of a Blood-Based Biomarker Signature Using Machine Learning for Early Differentiation of Pediatric Respiratory Syncytial Virus Infection from Mycoplasma Pneumonia in Hospitalized Patients

At a Glance

CategoryDetail
Condition
Key MechanismsDifferentiation of HRSV and MP infections using a blood-based biomarker signature
Target Population
Care Setting

Key Highlights

  • Development of a five-biomarker signature for distinguishing HRSV from MP infections
  • Optimized random forest model achieved an AUC-ROC of 0.89

Guideline-Based Recommendations

Diagnosis

  • Utilize blood-based biomarker signature for rapid differentiation of HRSV and MP

Management

    Monitoring & Follow-up

    • Evaluate the performance of the biomarker signature in diverse populations

    Risks

    • Inappropriate antimicrobial use due to diagnostic ambiguity

    Patient & Prescribing Data

    Clinical Best Practices

      Related Resources & Content

      Original Source(s)

      Related Content